SLACK, Inc.

SHERPA: Unknown

People

  1. Brennan
    Brennan
  2. Houghton
    Houghton
  3. Dupont
    Dupont
  4. Kelsen
    Kelsen
  5. McCormick
    McCormick
  6. Myskowski
    Myskowski
  7. Norton
    Norton
  8. O'Reilly
    O'Reilly

Groups

  1. Sloan Kettering Institute Faculty (5)
  2. Department of Medicine (4)
  3. Immunology Program Faculty (3)
  4. Molecular Pharmacology and Chemistry Program Faculty (2)
  5. Sarcoma Surgeons (2)
  6. Solid Tumor Oncology Division (2)
  7. Surgery (2)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  9. Breast Medicine Service (1)
  10. Center for Molecular Imaging and Biotechnology (1)
Search Within
  1. "1989"
Formats
  1. Meeting Abstract (18)
  2. Journal Article (1)
Groups
  1. Sloan Kettering Institute Faculty (5)
  2. Department of Medicine (4)
  3. Immunology Program Faculty (3)
  4. Molecular Pharmacology and Chemistry Program Faculty (2)
  5. Sarcoma Surgeons (2)
  6. Solid Tumor Oncology Division (2)

More Groups

People
  1. Maurie Markman (4)
  2. Alan Houghton (2)
  3. John Pinto (2)
  4. Murray Brennan (2)
  5. Neal Flomenberg (2)
  6. Peter Pisters (2)

More People

Years
  1. 1989 (19)
Publications
  1. Clinical Research (18)
  2. Journal of Pediatric Ophthalmology and Strabismus (1)

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Modulation of a glycolipid antigen, GD3, in human malignant melanoma
    Meeting Abstract

    Granberry, M. E.; Leong, S. P. L.; Houghton, A. N.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • Intraperitoneal (IP) cisplatin (DDP) and mitomycin (M) as treatment for malignant peritoneal mesothelioma (PM)
    Meeting Abstract

    Markman, M.; Kelsen, D.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • Growth inhibition as a primary mechanism for prolongation of time-to-relapse of breast cancer following adjuvant chemotherapy
    Meeting Abstract

    Norton, L.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • Transplant of human fetal dopamine cells in a patient with Parkinson's disease
    Meeting Abstract

    Freed, C. R.; Breeze, R.; Rosenberg, N.; Barrett, J. N.; Rottenberg, D. A.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • AE(1) cytokeratin patterns in differentiation states of squamous cell carcinoma of the esophagus
    Meeting Abstract

    Yang, K.; Lipkin, M.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • Regulation of genes for perforin and serine esterases in the human T leukemia cell line (JURKAT)
    Meeting Abstract

    Cha, I.; Trapani, J. A.; Dupont, B.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • A model to examine cost versus benefit of anti-neoplastic therapy
    Meeting Abstract

    Markman, M.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • Support for an advantage of intraperitoneal (IP) cisplatin (DDP) therapy (RX) over continued intravenous (IV) cisplatin in patients with residual ovarian-carcinoma (ROC)
    Meeting Abstract

    Markman, M.; Hakes, T.; Reichman, B.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • Studies on RAS oncogene mutations in malignant melanomas and dysplastic nevi
    Meeting Abstract

    McNutt, N. S.; Mentle, I. R.; Albino, A. P.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • Effects of amount and type of dietary fat upon the zinc-vitamin E interaction
    Meeting Abstract

    Bunk, M. J.; Dnistrian, A. M.; Smith, C.; Schwartz, M. K.; Rivlin, R. S.
    Clinical Research (1989)

    Fulltext@MSK | Save

    • SLACK, Inc. – authorized name for: